AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding AbCellera Biologics Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 86 | 114 | +28 |
| Shares | 71.2M | 90.6M | +19.4M (+27.2%) |
| Value | $2.42B | $1.99B | −$431.1M (−17.8%) |
New holders (48)
Institutions that held AbCellera Biologics Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (20)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Viking Global Investors LPSuperinvestorViking Global Investors | 19,083,744 | $648.1M |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 659,750 | $22.4M |
| Ameriprise Financial Inc | 524,690 | $17.8M |
| Pura Vida Investments, LLC | 225,000 | $7.64M |
| Canada Pension Plan Investment Board | 125,000 | $4.25M |
| Marshall Wace North America L.P. | 77,638 | $2.64M |
| Skandinaviska Enskilda Banken AB (publ) | 65,000 | $2.23M |
| HRT Financial LP | 27,366 | $929.0K |
| Paloma Partners Management Co | 26,592 | $903.0K |
| Two Sigma Advisers, LP | 20,800 | $706.0K |
| Centiva Capital, LP | 15,755 | $535.0K |
| Avidian Wealth Solutions, LLC | 13,000 | $441.0K |
| Walleye Capital LLC | 10,593 | $360.0K |
| Caas Capital Management LP | 10,000 | $340.0K |
| Paragon Advisors, LLC | 8,840 | $300.0K |
| Lumina Fund Management LLC | 3,000 | $102.0K |
| Deutsche Bank AG | 2,395 | $81.0K |
| FNY Investment Advisers, LLC | 602 | $20.0K |
| Quantbot Technologies LP | 435 | $14.0K |
| Sowell Financial Services LLC | 166 | $5.00K |